Molecular mechanisms of semaglutide and liraglutide as a therapeutic option for obesity

Molecular mechanisms of semaglutide and liraglutide as a therapeutic option for obesity

Obesity, a chronic global health problem, is associated with an increase in various comorbidities, such as cardiovascular disease, type 2 diabetes mellitus, hypertension, and certain types of cancer. The increasing global prevalence of obesity requires research into new therapeutic strategies. Gluca...

Full description

Bibliographic Details
Main Authors: Rafael Tamayo-Trujillo, Viviana A. Ruiz-Pozo, Santiago Cadena-Ullauri, Patricia Guevara-Ramírez, Elius Paz-Cruz, Raynier Zambrano-Villacres, Daniel Simancas-Racines, Ana Karina Zambrano
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-04-01
Series:Frontiers in Nutrition
Subjects:
obesity
molecular mechanism
semaglutide
liraglutide
weight loss
Online Access:https://www.frontiersin.org/articles/10.3389/fnut.2024.1398059/full

Internet

https://www.frontiersin.org/articles/10.3389/fnut.2024.1398059/full

Similar Items